Showing results (101-110 of 217) with videos related to
Sort By:
Pageof 22
Pediatric Blood & Cancer|May 31, 2020
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectVeronica Moroz, David Machin, Barbara Hero, et al.Oncotarget|October 25, 2016
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acidsAlexandre Chlenski, Marija Dobratic, Helen R Salwen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group studyLisa A Moreau, Patrick McGrady, Wendy B London, et al.Pediatric Blood & Cancer|September 22, 2012
Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progressionAndres Morales La Madrid, Melanie Beglin Nall, Karen Ouyang, et al.Pediatric Blood & Cancer|March 18, 2014
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastomaAlissa Martin, Jennifer Schneiderman, Irene B Helenowski, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 25, 2025
Neighborhood sociome factors and pediatric asthma exacerbations: Protective role of tree crown density and importance of pharmacy access in Chicago's south sideSandra Tilmon, Shashi Bellam, Kathy Bobay, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group databaseRochelle Bagatell, Maja Beck-Popovic, Wendy B London, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group studyRani E George, Wendy B London, Susan L Cohn, et al.Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.Pediatric Blood & Cancer|August 15, 2022
Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)Kirk D Wyatt, Suzi Birz, Douglas S Hawkins, et al.Pageof 22